Magnetic nanohydroxyapatite–peptide silk fibroin hydrogel induces osteogenesis in canine periodontal ligament stem cells revealed by proteomic analysis Authors: Steven Dwi Purbantoro, Marta Scatena, Teeanutree Taephatthanasagon, Watchareewan Rodprasert, Poorichaya Somparn, Saharat Nanthawong, Jiradej Makjaroen, Pongsakorn Jantaratana, Rangsini Mahanonda, Noppadol Sa-Ard-Iam, Thanaphum Osathanon, Sirinun Pisamai Tabtieang, Chenphop Sawangmake, Sirirat Rattanapuchpong Published: 2026 ABSTRACT ABSTRACTThe architecture of bone defects presents a challenge in designing scaffolds that support structural integrity and enhance osteoinduction. To address this, a noninvasive injectable silk fibroin (SF)-based hydrogel incorporating magnetic nanohydroxyapatite (MHAp) and osteogenic growth peptide (OGP) was developed. This study investigated the osteogenic differentiation potential of the hydrogel and its underlying mechanism on canine periodontal ligament stem cells (cPDLSCs). The incorporation of MHAp and/or OGP significantly enhanced osteogenic differentiation as evidenced by increased alkaline phosphatase activity, osteogenic marker expression, and biomineralization. Proteomics analysis revealed that TGF-β, BMP, and Notch signaling pathways were involved in hydrogel-induced osteogenic differentiation, which was further validated by an inhibition assay. Overall, the injectable SF hydrogel containing MHAp and OGP demonstrates strong potential for clinical application in the treatment of alveolar bone defects. Introduction Periodontitis is an inflammatory condition affecting the periodontal tissues, which occurs not only in human but also in animals, such as dog, cat, deer mouse, and Macaca mulatta (Wiebe et al. 2001; Niemiec 2008; Colombo et al. 2017). The condition is caused by bacterial infections, mainly Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. The periodonthopathogenic bacteria resides on the tooth surface and progress to form biofilm on the gingival inducing inflammation, which induces the expression of matrix metalloproteases (MMPs) and apoptosis-related cytokines. This leads to the destruction of the gingival tissue and results in the formation of a periodontal pocket. The progression also destroys the periodontal ligament by the increased expression of MMPs, leading to the attachment loss (Könönen et al. 2019). In severe periodontitis, the microstructure of cementum is altered, assumed the periodontopathogenic bacteria affects acid/base and oxidation/reduction reactions against the organic matrix, altering the surface integrity andcytokine to breakdown ECM (Junka et al. 2015; Li et al. 2019). It leads to bone defects in the alveolar bone due to the progression of bone resorption (Niemiec 2008). The progression starts when periopathogens produce harmful products and enzymes that disintegrate the extracellular matrix in the bone tissue. Moreover, when lipopolysaccharides of periopathogens and infiltrated leukocyte-derived interleukin 1 are exposed to osteoblasts and periodontal ligament fibroblasts, RANKL is expressed, increasing the RANKL/OPG ratio to promote osteoclast development leading to bone resorption (Hienz et al. 2015). The bone resorption subsequently causes bone loss, which can be horizontal, vertical, and/or furcation defects, which can be visualized by radiographs (Kurt-Bayrakdar et al. 2024). If left untreated, advanced periodontitis-induced bone resorption can result in pathological fracture, which small-breed dogs are prone to this complication due to dental crowding (Gioso et al. 2001; Niemiec 2008; Scherer et al. 2019), causing significant burdens on both animals and their owners. To prevent such complications, bone tissue engineering (BTE) has emerged as a promising strategy for bone regeneration. Guided bone regeneration (GBR) is a widely used technique in periodontal therapy for the treatment of bone defects. It involves the placement of a barrier membrane over the defect to promote selective cell repopulation. The membrane prevents the rapid migration of epithelial cells and fibroblasts into the defect site, thereby allowing slower-growing osteogenic cells to populate the area and facilitate new bone formation. Additionally, the membrane helps maintain a stable space for blood clot formation, which serves as a scaffold for tissue regeneration and prevents soft tissue collapse into the defect (Hitti and Kerns 2011). However, the irregular architecture of either horizontal, vertical, or furcation bone defects remains a major challenge to overcome. A minimally invasive approach using an injectable polymer derived from Bombyx mori, has attracted attention due to its biocompatibility, injectability, and capacity to support bone regeneration (Ciocci et al. 2018; Wang et al. 2020; Chuysinuan et al. 2021; Sun et al. 2021). Notably, SF lysates have also demonstrated potential in reducing osteoclastogenesis and promoting osteoclast apoptosis (Jones et al. 2009; Chon et al. 2012). The functionality of SF-based hydrogel can be enhanced by incorporating additional bioactive components. Magnetic nanohydroxyapatite (MHAp), a modified form of nanohydroxyapatite with intrinsic bone-like composition, has shown superior regenerative properties compared to its nonmagnetic counterpart (Hu et al. 2018; Russo et al. 2018). Previous studies have demonstrated that the integration of magnetic particles into SF hydrogel improves their osteoinductive potential (Tanasa et al. 2020; Ma et al. 2022). Furthermore, osteogenic growth peptide (OGP), a 14-amino acid peptide, has been shown to enhance the osteogenic differentiation of mesenchymal stem cells (MSCs) (Vanella et al. 2010; Chen et al. 2011; Purbantoro et al. 2022). Based on this knowledge, the present study aimed to develop an injectable silk fibroin hydrogel incorporating MHAp and OGP and to evaluate its potential and underlying mechanisms. Canine periodontal ligament stem cells (cPDLSCs) were used as a model due to their known osteogenic potential and their origin within the alveolar bone socket (Zhu and Liang 2015). Proteomics analysis was employed to further elucidate the signaling pathways involved in hydrogel-induced osteogenic differentiation of cPDLSCs. Materials and methods Canine periodontal ligament stem cell (cPDLSC) isolation and culture The study protocol to use cPDLSCs has been approved by the Institutional Animal Care and Use Committee (IACUC), Faculty of Veterinary Science, Chulalongkorn University (Animal Use Protocol No. 2231041). The mid-third portion of periodontal ligament tissues from clinically healthy donor dogs post-jaw trauma and/or with malocclusion requiring tooth extraction without periodontal disease signs, according to the American Veterinary Dental College (AVDC), was harvested from the Small Animal Teaching Hospital, Faculty of Veterinary Science, Chulalongkorn University, upon the owner's consent for the study participation. The collected tissue was explanted and cultured in growth medium that contains Dulbecco's Modified Eagle Medium (DMEM) (Cat#12800-017) supplemented with 10% fetal bovine serum (FBS) (Cat#10270-106), 1% GlutaMAX™-I (Cat#35050-061), 1% antibiotic-antimycotic (Cat#15240-062). Cells were subcultured at 70%–80% confluency. Cells at passages 3–5 were used in this study. Flow cytometry Flow cytometry was performed to analyze the MSC markers (CD73, CD90, CD44, and CD29) and hematopoietic stem cell (HSC) marker (CD45). Single cPDLSC suspension was stained with FITC-conjugated mouse anti-human CD45 monoclonal antibody (mAb) (Cat#368508), FITC-conjugated mouse anti-human CD73 mAb (Cat#344016), FITC-conjugated goat anti-mouse IgG secondary antibody (Cat#STAR117F), PE-conjugated rat anti-dog CD90 mAb (Cat#1TFS-AB-12-5900-42), Alexa Fluor 488-conjugated rat anti-dog CD44 mAb (Cat#MCA1041A488), and PE-conjugated mouse anti-human CD29 mAb (Cat#3303004). FITC-conjugated mouse IgG1 kappa Isotype (Cat#400110), mouse IgG2a kappa Isotype (Cat#400201), and PE-conjugated rat IgG2b kappa Isotype (Cat#400608) were employed in this study as isotype controls. The stained cells were analyzed using a FACSCalibur flow cytometer. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) Total mRNA was extracted using the Zymo kit (Cat# R2052) following the manufacturer's protocol from previously collected cells in TRIzol™ (Cat#15596026). Conversion of mRNA into cDNA was done with a Promega kit (Cat#A3800). Next, RT-qPCR was performed using LUNA Master Mix (Cat#M3003L) on a CFX Connect™ Optics Module (BioRad), and the cycle threshold was measured with Bio-Rad CFX Maestro software. The calculation of mRNA expression used the following formula of 2−ΔCt, whereas ΔCt = Cttarget gene − Ctreference gene. As for experiments with more than one group, the expression was calculated by comparing with the control group with the following formula of 2−ΔΔCt, whereas ΔΔCt = ΔCttreatment group − ΔCtcontrol group. The calculation was normalized to GAPDH as the reference gene. Primer sequences used in this study are shown in Supplementary Table S1. Colony-forming assay A 1.5 × 103 cells in a 60-mm dish, cPDLSCs were seeded and maintained for 14 days in growth medium. Cells were then fixed with cold methanol at 4 °C for 20 min and stained with crystal violet (Cat#94448). The stained cells were subjected to a colony count with the criterion that one colony contains at least 50 cells. Osteogenic differentiation in vitro Following the previous study (Nantavisai et al. 2020), cPDLSCs were seeded at 3.5 × 104 cells/well in a 24-well plate and cultured for 14 days. The cells were induced under osteogenic medium that was growth medium supplemented with 50 µg/mL ascorbic acid (Cat#A4034), 250 nM dexamethasone (Cat#D4902), and 5 mM β-glycerophosphate (Cat#G9422). Alizarin Red S staining Prior to staining, the osteogenic-induced cells were fixed with cold methanol at 4 °C for 20 min. The fixed cells were then stained with 2% Alizarin Red S solution (Cat#A5533) in distilled water at pH 4.2 at RT. Adipogenic differentiation in vitro At a density of 3 × 104 cells, cPDLSCs were seeded in a 24-well plate and maintained for 23 days to be differentiated into adipogenic lineage following previous studies (Nantavisai et al. 2020; Rodprasert et al. 2021; Dang Le et al. 2022; Purbantoro et al. 2022; Purwaningrum et al. 2023) With four induction cycles, adipogenic induction medium contains growth medium supplemented with 1 µM dexamethasone, 0.1 mM indomethacin (Cat#I7378), 1 mM 3-isobutyl-1-methylxanthine (IBMX) (Cat#I5879), and 1 µg/mL insulin (Cat#I6634) was used for 72 h and adipogenic maintain medium contains growth medium supplemented with 1 µg/mL insulin was used for the next 24 h. Oil Red O staining A 4% formaldehyde solution was used to fix the adipogenic-induced cPDLSCs for 1 h. The cells were then stained with 0.1% Oil Red O solution (Cat#O0625) in isopropanol and kept in PBS for observation. Chondrogenic differentiation in vitro The chondrogenic differentiation was performed according to previous studies (Nantavisai et al. 2020; Rodprasert et al. 2021; Dang Le et al. 2022; Purbantoro et al. 2022; Purwaningrum et al. 2023). The cPDLSCs were seeded at 5 × 104 cells/well in a 24-well plate and maintained for 21 days under induction media consisting of growth medium supplemented with 15% FBS, 10 ng/mL transforming growth factor (TGF)-β3, 50 µg/mL ascorbic acid, 0.4 mg/mL L-Proline (Cat#P0380), 0.1 µM dexamethasone, and 1% insulin-transferrin-selenium (Sueishi et al. 2020) (Cat#41400045). Alcian blue staining A 0.1% alcian blue (Cat#A5268) solution in 3% acetic acid was used to fix the cells after cell fixation with 4% paraformaldehyde for 1 h. Magnetic nanohydroxyapatite synthesis and characterization The synthesis of MHAp followed the study of Wu et al. (2007). In brief, 0.3 M orthophosphoric acid (H3PO4, Cat#695017) was added at 3 mL/min rate into a 0.5 M calcium hydroxide (Ca(OH)2, CAS#1305650) at 85 °C in a shaking water bath with 100 rpm to create a stoichiometric amount at 1.67 Ca/P molar ratio. Ammonium hydroxide solution (NH4OH, Cat#221228) was then added to the mixture to adjust the pH to 8.5. The mixture was stirred for 2 h at 400 rpm and allowed to age overnight at room temperature (RT). The next day, at a molar ratio XFe/Ca = 0.8, iron (II) chloride tetrahydrate (FeCl2·4H2O, Cat#44939) was added into the aged suspension with a rate of 1 mL/min at 85 °C in a shaking water bath at 100 rpm. The NH4OH was added again to adjust the pH to 8.5. Another stirring for 2 h at 400 rpm and aging overnight at RT were done. The final aged suspension was termed as MHAp suspension and later washed with double-distilled water three times by stirring at 400 rpm for 1 min at RT and allowed to age for 2 h. The supernatant was discarded, and the aqueous suspension was freeze-dried for further use. X-ray diffraction (XRD) The MHAp crystal structure was analyzed with XRD (D8 Discover, Bruker) within a 2θ range of 10°–60° by Cuκα (λ = 1.5406 Å) radiation. The crystallite size and spectra were analyzed in reference to the hydroxyapatite (The International Center for Diffraction Data (ICDD) No. 01-074-0565) with Profex5 software. Electron microscopy (EM) and energy dispersive X-ray spectroscopy (EDX) The MHAp properties of morphology and element components were analyzed with a field emission scanning EM (FE-SEM) and EDX (S-4800). The hydrogels were analyzed for their morphology with an SEM (Quanta250). Both MHAp and hydrogels were coated on a carbon film on the surface by sputtering platinum (E-1010 Ion Sputter) and captured using 10 kV and 20 kV, respectively. Nanotracking analysis (NTA) The particle size distribution of MHAp was determined with an NTA (NanoSight NS300). The MHAp suspension in double-distilled water was injected by an automatic syringe pump. The results were analyzed with NanoSight NTA 3.2 software. Fourier-transform infrared spectroscopy (FTIR) An FTIR (Nicolet Nexus IS5) was used to analyze the functional groups of MHAp and hydrogels. Measurement of each spectrum was done for 32 scans between 650 and 4000 cm−1 wavelengths in the transmission mode by the potassium bromide (KBr) method. The results were shown in Percent Transmittance. Vibrating sample magnetometer (VSM) The MHAp magnetic property was analyzed with a VSM (custom-made by the Department of Physics, Kasetsart University, Thailand). An applied magnetic field at 15 kOe was used at RT. A 3 mm diameter Ni sphere (Lake Short 730908) was employed to calibrate the system as a standard reference. The result was shown as magnetization (M) for magnetic moment m per total mass of the specimen. Hydrogel preparation Preparation of hydrogel employed 5% silk fibroin (SF) solution (Cat#5154), 3% sodium alginate (SA) (Cat#W201502), and 100 mM calcium chloride (CaCl2, CAS#10035048) in an aseptic condition, which each material had been autoclaved before, to reach final concentration at 2%, 1.3%, and 16.67% v/v, respectively, by ultrasonication (CE-1100D) at RT. Before the addition of CaCl2, OGP (Cat#HYP1563) and/or MHAp were added into the mixture and ultrasonicated at RT. The final product was used freshly for the cell culture, while freeze-dried for characterization. Extract media was collected by incubating fresh hydrogel in respective media at a ratio of 0.2 g/mL, according to the ISO 10993-12-2021. Injectability assay The injectability property of the hydrogels was determined by the injectability assay. A 500 µL of each hydrogel was loaded in a 1 mL syringe without or with a needle (18 G, 21 G, 22 G, or 23 G). The loaded syringe was placed vertically to bear 200 g for 10 s. The Percent Injectability was calculated by the following equation:%Injectability=Preinjectedmass(g)−Postinjectedmass(g)Preinjectedmass(g)×100%. Swelling assay The capability of hydrogels to absorb water was evaluated using freeze-dried hydrogels for its water content by following the previous reported study (Torsahakul et al. 2022). The initial weight was measured as W0. The hydrogels were then soaked in phosphate buffer saline (PBS, pH 7.4) in the incubator at 37 °C for 24 h. After incubation, tissue paper was used to blot the excess water for further weight measurement (Wt). The percent water absorption was calculated by the following equation:%WaterAbsorption=Wt−W0Wt×100%. In vitro enzymatic degradation Following the previous study (Torsahakul et al. 2022), the assay employed the degradation solution containing 1 U/mL protease XIV (pH 7.4, Cat#P5147) and 0.01% w/v sodium azide (Cat#S2002) in PBS (pH 7.4). Before immersion in the solution, the freeze-dried hydrogels were weighed (W0) and later incubated at 37 °C for 14 days with an interval of 2 days for solution replacement. After incubation, the immersed hydrogels were washed with distilled water and centrifuged at 10,000 rpm for 5 min and dried in an oven at 60 °C overnight. The dried hydrogels were weighed (Wt) and calculated for percent degradation with the following equation:%Degradation=W0−WtW0×100%. Mechanical property Freeze-dried hydrogels were analyzed in a Universal Testing Machine (EZ-S 500 N, SHIMADZU) to determine mechanical properties with a load of 500 N, with a constant strain rate at 1 mm/min. Resazurin assay Proliferation of cells was analyzed using resazurin (Cat#R7017) solution in growth medium at a final concentration of 0.015 mg/mL. The cells were incubated for 3 h before absorbance measurement at 570 and 600 nm wavelengths with a spectrophotometer. Live/dead assay Live/dead assay was performed by following the previous study (Purbantoro et al. 2022). The assay employed Calcein-AM (Cat#C1430) and propidium iodide (PI) (Cat#P21493) in PBS by incubating the cells for 20 min. The stained cells were observed under a confocal microscope. Alkaline phosphatase (ALP) activity assay Before the start of the reaction, cells were lysed using a lysis buffer consisting of 0.1% Triton X-100, 1 M Tris–HCl, and 5 mM MgCl2 according to previous reports (Sawangmake et al. 2016; Nantavisai et al. 2020; Purbantoro et al. 2022; Purwaningrum et al. 2023). The lysate was incubated with p-nitrophenol phosphate (PNPP) (Cat#002201), 2-amino-2-methyl-1-propanol (Cat#A65182), and 2 mM MgCl2 for 15 min at 37 °C. A 0.1 M NaOH solution was added to quench the reaction, and absorbance was measured using a spectrophotometer at 410 nm. Additionally, total protein concentration was measured with Qubit™ Protein Assay kit (Cat#Q33211) following the manufacturer's protocol. The ALP activity was calculated in the U/mg protein unit. Protein extraction and in-solution digestion Protein extraction was performed by following the protocol of the EasyPep™ Mini MS Sample Prep Kit (Cat#A40006), followed by protein concentration measurement using a bicinchoninic acid (BCA) assay kit (Cat#23225). Briefly, the protein in 1× protease inhibitor (Cat#87786) and 8 M urea in 100 mM tetraethylammonium bromide (TEAB) was reduced and alkylated using tris(2-carboxyethyl) phosphine (TCEP) and iodoacetamide (IA), respectively. The samples were then digested and quenched after incubation for 3 h. The peptides were then cleaned up with the same sample preparation kit and evaporated using vacuum centrifugation. The products were then resuspended in 0.1% formic acid (FA). The digested proteins were quantified using a Pierce™ Quantitative Fluorescent Peptide Assay (Cat#23290). LC–MS/MS and analysis The resuspended samples were injected into the EASY nLC1000 system (Thermo Scientific) connected to a Q-Exactive Orbitrap Plus mass spectrometer (Thermo Scientific) supplied with a nano-electrospray ion source (Thermo Scientific) at a flow rate of 300 nL/min. Target peaks were selected at a range of 350–1400 m/z from the MS scan. Data acquisition and identification were performed using FragPipe v21.1 software using default settings for the label-free quantification (LFQ) method. Proteomics quantification The identified proteins were annotated using FragPipe-Analyst (http://fragpipe-analyst.nesvilab.org/) to exclude the proteins found in less than three replicates. The Log2 value was calculated as a result of the normalized ratio for mean and standard deviation of fold change and tested with an independent t-test to compare between groups. Proteomics analysis and visualization were made using https://bioinformatics.psb.ugent.be/webtools/Venn/, Instant Clue v0.12.2, String (https://string-db.org/), SRplot (Tang et al. 2023), and Reactome (https://reactome.org/). Inhibition assay Validation was performed under osteogenic induction conditions by the addition of an inhibitor of each relevant selected pathway for the biomineralization. The inhibitors used in this study included 4 µM Dorsomorphin (Cat#P5499), 100 ng/mL Dickkopf 1 (Dkk-1) (Cat#SRP3258), 4 µM SB-431542 (Cat#S4317), and 25 µM DAPT (Cat#D5942) for BMP, canonical Wnt, TGF-β, and Notch signaling pathways, respectively. Statistical analysis Comparison of more than two groups was done by using the Kruskal–Wallis test and followed by the Mann–Whitney U test for two independent groups with SPSS Statistics. p value less than 0.05 was used in this study as a significant level. Results MHAp was successfully synthesized with nanoscale and superparamagnetic properties MHAp was successfully synthesized by the coprecipitation method as brown-colored powder (Figure 1A). X-ray diffraction (XRD) analysis revealed that the crystal structure of MHAp closely resembled that of reference hydroxyapatite, with a calculated crystallite size of 42.4 nm (Figure 1B). Field-emission scanning electron microscopy (FE-SEM) presented spherical nanoparticles with an average diameter of approximately 87 nm (Figure 1C). Consistent with XRD and FE-SEM findings, nanoparticle tracking analysis (NTA) indicated a mode particle size of 56.4 nm (Figure 1D). Fourier-transform infrared spectroscopy (FTIR) identified characteristic absorption peaks at 659, 860, 1029, and 3375 cm−1, confirming the presence of phosphate and hydroxyl functional groups typical of hydroxyapatite (Figure 1E). In addition, magnetic property analysis demonstrated that the synthesized MHAp exhibited superparamagnetic behavior (Figure 1F), confirming its suitability for biomedical applications requiring magnetic responsiveness. Characterization of synthesized MHAp. (A) Gross appearance of MHAp. (B) XRD analysis of MHAp compared to the reference HAp (ICDD No. 01-074-0565). (C) Morphology of MHAp by FE-SEM analysis at 200,000× magnification. (D) NTA analysis of MHAp (n = 3, representative image from three replicates). (E) FTIR analysis of MHAp. (F) Magnetic property of MHAp by VSM analysis. OGP and MHAp exhibit proliferative effects without inducing cytotoxicity in cPDLSCs Before experimentation, the isolated cPDLSCs were characterized and confirmed to exhibit MSC properties. The cells displayed spindle-shaped morphology, expressed stemness and periodontal ligament markers, demonstrated colony-forming ability, and differentiated into multiple lineages (Figure 2). Characterization of cPDLSCs. (A) Morphology of isolated cPDLSCs (phase contrast microscopy representative image). (B) Surface marker expression of cPDLSCs by flow cytometry analysis (n = 4). (C) Expression of stemness, proliferation, and PDL markers by RT-qPCR normalized with GAPDH as the reference gene (n = 4). (D) Colony formation of cPDLSCs (n = 4, representative image from four replicates). (E) Quantification of cPDLSC colony formation (n = 4). (F) Biomineralization staining of osteogenic lineage differentiation of cPDLSCs by Alizarin Red S staining (representative image from four replicates). (G) Osteogenic marker expression of osteogenic lineage differentiation of cPDLSCs by RT-qPCR normalized with GAPDH as the reference gene (n = 4). (H) Extracellular matrix staining of chondrogenic differentiation of cPDLSCs by alcian blue staining (representative image from four replicates). (I) Chondrogenic marker expression of chondrogenic differentiation of cPDLSCs by RT-qPCR normalized with GAPDH as the reference gene (n = 4). (J) Lipid droplet staining of adipogenic differentiation of cPDLSCs by Oil Red O staining (representative image from four replicates). (K) Adipogenic marker expression of adipogenic lineage differentiation of cPDLSCs by RT-qPCR normalized with GAPDH as the reference gene (n = 4). Arrow indicates a colony, and arrowhead indicates a noncolony. Bar indicates p < 0.05, Mann–Whitney test; line indicates mean and standard deviation. Cytocompatibility was assessed by treating the cells with OGP at concentrations ranging from 0.01 to 1000 nM and MHAp at 0.2%–1% (%w/v) for up to 7 days in growth medium. Cell proliferation was evaluated using the resazurin assay, and cell viability was confirmed by live/dead (L/D) staining (Figure 3A). Cytocompatibility of OGP and MHAp on cPDLSCs. (A) Experimental design. The OGP at 0.1 to 1000 nM and MHAp at 0.2% to 1% w/v were used as treatment on cPDLSCs for resazurin assay and live/dead (L/D) staining for 7 days of culture. (B) Proliferation effect of OGP on cPDLSCs by resazurin assay (n = 4). (C) Proliferation effect of MHAp on cPDLSCs by resazurin assay (n = 4). (D) Viability of cPDLSCs under OGP treatment by L/D staining (n = 4, representative image from four replicates). Green indicates viable cells and red indicates dead cells. (E) Viability of cPDLSCs under MHAp treatment by L/D staining (n = 4, representative image from four replicates). Green indicates viable cells and red indicates dead cells. * and # indicate the statistically significant difference to the control each day and to the respective group on day 1, respectively, at p < 0.05, Mann–Whitney test; line indicates mean and standard deviation. The OGP treatment significantly enhanced cell proliferation starting from day 1 at 0.1, 1, 10, and 100 nM, with sustained effects through days 5 and 7. Notably, only the 100 nM concentration exhibited a statistically significant difference compared to the control (Figure 3B). The L/D staining showed minimal red-stained (dead) cells, confirming the absence of cytotoxicity (Figure 3D). The MHap did not initially promote proliferation compared to the control. However, by day 5, a dose-dependent increase in proliferation was observed relative to day 5 control group, despite an overall decrease compared to day 1 (Figure 3C). On day 7, lower concentrations of MHAp (0.2, 0.4, and 0.6% w/v) supported greater proliferation than higher concentrations (0.8 and 1% w/v). Similar to OGP, MHAp treatment resulted in negligible cytotoxicity, as evidenced by the absence of red-stained dead cells in L/D staining (Figure 3E). These results indicate that both OGP and MHAp promote proliferation and are cytocompatible with cPDLSCs in vitro. Hydrogel characteristics Based on previous experiments, concentrations at 100 nM for OGP and 0.6% w/v for MHAp were selected for subsequent studies. The gross morphology of hydrogels before and after crosslinking is shown in Figure 4A. There was no difference between HG and HG/OGP with a clear appearance, while HG/MHAp and HG/OGP/MHAAp showed a brownish and opaque appearance. Characteristics of hydrogels. (A) Gross appearance of hydrogels before and after cross-linking with CaCl2. (B) Injectability and quantification of hydrogels without and with needles of 18, 21, 22, and 23 G (n = 4, representative image from four replicates). (C) Morphology of freeze-dried hydrogels at 200, 500, and 1000× by SEM analysis (representative image). (D) Pore distribution quantification of (C) from 300 pores. (E) FTIR analysis of sodium alginate (SA), silk fibroin (SF), and hydrogels. (F) Degradation and swelling profiles of hydrogels. (G) Mechanical properties of hydrogels. (H) Experimental design. Extract hydrogels were used to treat cPDLSCs for the resazurin assay and L/D staining for 7 days of culture. (I) Proliferation effect of hydrogels on cPDLSCs by resazurin assay (n = 4). (J) Viability of cPDLSCs under hydrogel treatment by L/D staining (n = 4, representative image from four replicates). Green indicates viable cells and red indicates dead cells. * and # indicate the statistically significant difference to the control each day and to the respective group on day 1, respectively, at p < 0.05, Mann–Whitney test; line indicates mean and standard deviation. Injectability assay revealed that all hydrogels were easily extruded using 18 G, 21 G, and 22 G needles, with up to ~98% injectability. However, the use of a 23 G needle significantly reduced injectability up to ~70% (Figure 4B). Scanning electron microscopy (SEM) revealed an interconnected porous structure in all hydrogels, with average and standard deviation of pore size distribution at 61.18 ± 20.94, 54.66 ± 18.07, 54.88 ± 14.20, and 47.23 ± 14.09 µm for HG, HG/OGP, HG/MHAp, and HG/OGP/MHAp, respectively (Figure 4C,D). The FTIR spectroscopy showed characteristic peaks around 3265, 1636, 1534, 1239, and 1028 cm−1, confirming the chemical composition of the silk-fibroin-based hydrogel and its modifications (Figure 4E). In degradation studies, HG/OGP/MHAp showed the lowest degradation rate over 14 days, followed by HG/MHAp, HG/OGP, and HG alone. Conversely, the swelling assay indicated that unmodified HG appeared to have the highest swelling ratio, followed by OGP- and/or MHAp-incorporated hydrogels. Most groups reached equilibrium within 2 h (Figure 4F). Mechanical testing revealed that incorporation of OGP and/or MHAp reduced both Young's modulus and compressive strength compared to unmodified HG (Figure 4G). Cytocompatibility testing, as schemed in Figure 4H, demonstrated enhanced cell proliferation in all hydrogel groups containing OGP and/or MHAp compared to the HG group and untreated control (Figure 4I). Additionally, L/D staining confirmed the absence of cytotoxicity, with no observable, red-stained dead cells in any group (Figure 4J). Overall, the incorporation of OGP and MHAp improved several functional properties of the SF hydrogel, including bioactivity, injectability, degradation behavior, and cytocompatibility. HG/OGP/MHAp possessed osteogenic differential potential of cPDLSCs in vitro To assess the osteogenic differentiation potential, monolayer cPDLSCs were treated with OM and extraction media from the hydrogels and evaluated for alkaline phosphatase (ALP) activity, osteogenic gene expression, and biomineralization, as outlined in the experimental scheme in Figure 5A. The ALP activity was enhanced in all groups treated with OGP and/or MHAp-incorporated hydrogels on both days 7 and 14, with the highest activity observed in the HG/OGP/MHAp group (Figure 5B). Quantitative PCR analysis revealed the upregulation of osteogenic-related genes Runx2, OSX, and Col1A1 on day 7 in OGP- and/or MHAp-treated groups. On day 14, Runx2 and ALP were upregulated, while OSX and Col1A1 expression levels decreased (Figure 5C), suggesting temporal regulation of osteogenic markers during differentiation. Alizarin Red S staining confirmed enhanced biomineralization in cells treated with hydrogels containing OGP and/or MHAp, with the most pronounced in the HG/OGP/MHAp group (Figure 5D,E). These findings indicate that the injectable silk fibroin hydrogel containing both OGP and MHAp effectively promotes osteogenic differentiation of cPDLSCs in vitro. Osteogenic differentiation potential of cPDLSCs under hydrogel treatment. (A) Experimental design. Extract hydrogels were used to treat cPDLSCs under osteogenic induction medium for alkaline phosphatase (ALP) activity, osteogenic marker expression, and biomineralization staining for 14 days of culture. (B) The ALP activity of cPDLSCs under hydrogel treatment by ALP assay (n = 4). (C) Osteogenic marker expression of cPDLSCs under hydrogel treatment by RT-qPCR normalized with GAPDH as the reference gene (n = 4). (D) Biomineralization staining of cPDLSCs under hydrogel treatment by Alizarin Red S staining (representative image from four replicates). (E) Quantification of (D) by the elution method (n = 4). * indicates the statistically significant difference to the control each day at p < 0.05, Mann–Whitney test; line indicates mean and standard deviation. Distinct proteome profiles induced by OGP and/or MHAp incorporation into hydrogel To disseminate the mechanisms underlying hydrogel-induced osteogenic differentiation, proteomics profiling was conducted on cPDLSCs treated with hydrogels on days 7 and 14 (Figure 6A). On day 7, a total of eight proteins were commonly expressed across all hydrogel groups, while 9, 20, and 47 unique proteins were identified in HG/OGP, HG/MHAp, and HG/OGP/MHAp groups, respectively. In contrast, the day 14 analysis revealed no commonly shared proteins, with 6, 59, and 47 unique proteins identified in HG/OGP, HG/MHAp, and HG/OGP/MHAp, respectively (Figure 6B,C). Cluster heatmap analysis indicated differences in protein expression patterns, forming two distinct clusters on day 7 and three clusters on day 14 (Figure 6D,E). Volcano plots demonstrated similar protein expression trends among groups on day 7, with HG/OGP/MHAp exhibiting a higher number of significantly expressed proteins compared to HG/OGP and HG/MHAp (Figure 6F). On day 14, HG/OGP showed a lower number of significant proteins than other groups, while HG/OGP/MHAp displayed fewer significant proteins compared to HG/MHAp (Figure 6G). Gene ontology (GO) enrichment analysis for biological processes (BP), molecular functions (MF), and cellular components (CC) revealed consistent trends between days 7 and 14 (Figure 6H,I). These results indicate that the incorporation of OGP and/or MHAp into the hydrogel induces distinct proteomics signatures in cPDLSCs potentially contributing to their osteogenic differentiation capacity. Proteomics analysis of cPDLSCs under hydrogel treatment toward osteogenic lineage. (A) Experimental design. Extract hydrogels were used to treat cPDLSCs under osteogenic induction medium for proteomics analysis for 14 days of culture (n = 5). (B) Venn diagram analysis of significantly expressed proteins from day 7, compared to HG as control. (C) Venn diagram analysis of significantly expressed proteins from day 14, compared to HG as control. (D) Cluster heat map analysis of identified proteins from day 7, compared to HG as control. (E) Cluster heat map analysis of identified proteins from day 14, compared to HG as control. (F) Volcano plot analysis of identified proteins from day 7, compared to HG as control. Blue dot indicates protein was significantly different at p < 0.05. (G) Volcano plot analysis of identified proteins from day 14, compared to HG as control. Blue dot indicates protein was significantly different at p < 0.05. (H) Gene ontology analysis of identified proteins from day 7 for biological processes (BP), molecular functions (MF), and cellular components (CC). (I) Gene ontology analysis of identified proteins from day 14 for BP, MF, and CC. The osteogenic potential of HG/OGP/MHAp on cPDLSCs is regulated by TGF-β, BMP, and Notch signaling pathways To elucidate the molecular mechanisms underlying hydrogel-induced osteogenesis, signaling pathways regulating the osteogenic differentiation of cPDLSCs were analyzed using Reactome database (Figure 7A). The enrichment results identified several pathways potentially involved in osteogenic regulation, which are visualized in heatmap analysis (Figure 7B). Based on their relevance to bone formation, the Wnt, transforming growth factor-beta (TGF-β), bone morphogenic protein (BMP), and Notch signaling pathways were selected for further validation using specific inhibitors. As outlined in the experimental scheme (Figure 7C), cPDLSCs were treated with Dkk-1 (Wnt inhibitor), SB-431542 (TGF-β inhibitor), Dorsomorphin (BMP inhibitor), and DAPT (Notch inhibitor), and biomineralization was assessed on days 7 and 14. The result revealed that SB-431542, Dorsomorphin, and DAPT significantly reduced biomineralization at both time points, indicating the involvement of TGF-β, BMP, and Notch signaling in mediating osteogenesis (Figure 7D,E). In contrast, Dkk-1 treatment did not significantly affect mineral deposition. Collectively, these findings suggest that TGF-β, BMP, and Notch signaling pathways are critical regulators of the osteogenic differentiation of cPDLSCs induced by HG/OGP/MHAp. Functional validation of cPDLSCs under hydrogel treatment toward osteogenic lineage. (A) Experimental design. Identified proteins from days 7 and 14 were used for Reactome analysis. (B) Heatmap analysis of signaling pathway-related identified proteins compared to HG as control. (C) Experimental design. Inhibitors of relevant signaling pathways were used for functional validation of cPDLSCs under HG/OGP/MHAp for biomineralization staining. (D) Biomineralization staining of cPDLSCs under HG/OGP/MHAp treatment with and without relevant inhibitors by Alizarin Red S staining (representative image from four replicates). (E) Quantification of (D) by elution method (n = 4). * indicates the statistically significant difference to the control each day at p < 0.05, Mann–Whitney test; line indicates mean and standard deviation. Discussion Injectable hydrogels represent a promising strategy for bone regeneration due to their excellent biocompatibility, minimally invasive delivery, and capability to incorporate both organic and inorganic bioactive agents. In this study, we developed an injectable SF-based hydrogel incorporating OGP and MHAp and evaluated its potential for promoting alveolar bone regeneration using cPDLSCs in vitro. Characterization of the synthesized MHAp confirmed its nanoscale crystallinity and successful iron doping. The material was synthesized via a coprecipitation wet chemical method, and XRD analysis confirmed that the crystal structure of hydroxyapatite was preserved post-doping, consistent with previous findings (Wu et al. 2007). According to the definitions provided by the American Society for Testing and Materials (ASTM E2456–06, reapproved 2020) and ISO 80004-1:2023(E), nanoparticles are defined as particles with dimensions ranging from 1 to 100 nm. The synthesized MHAp met this criterion, as supported by both XRD and NTA, which confirmed that the majority of particles were within the nanoscale range. Morphological assessment by FE-SEM revealed spherical nanoparticles, in agreement with prior studies (Wu et al. 2007). Furthermore, FTIR analysis exhibited characteristic peaks corresponding to phosphate (ν3 PO₄³⁻), carbonate (ν3 CO₃²⁻), and hydroxyl (OH⁻) groups in the ranges of 961–1091, 1400–1600, and 3200–3550 cm⁻¹, respectively, consistent with standard hydroxyapatite profiles (Koutsopoulos 2002; Varma and Babu 2005). The observed overlap of Fe–OH functional groups with the phosphate peak is indicative of successful Fe incorporation, as previously described (Mondal et al. 2017). Vibrating sample magnetometer (VSM) revealed a small hysteresis loop, confirming the superparamagnetic behavior of the Fe-doped HAp. Although the overall magnetization was low, it remained consistent with earlier studies utilizing a similar synthesis method (Wu et al. 2007), supporting its potential utility in magnetic-responsive biomedical applications. Following the criteria established by the International Society for Cellular Therapy (ISCT), the isolated cPDLSCs used in this study were confirmed to exhibit MSC characteristics. These included plastic adherence, expression of defined MSC surface markers, and the ability for multilineage differentiation (Dominici et al. 2006). Additionally, the cells expressed key pluripotency and proliferation markers, further supporting their stemness profile (Nantavisai et al. 2020; Rodprasert et al. 2021; Dang Le et al. 2022; Taephatthanasagon et al. 2024). The presence of S100A4 and POSTN, both of which are associated with periodontal ligament tissue, confirmed the origin of isolated cells (Iwata et al. 2009; Chen et al. 2013; Sedigh et al. 2023). Moreover, the colony-forming ability of cPDLSCs demonstrated their self-renewal and proliferative potential, which are essential properties of functional MSCs (Aponte and Caicedo 2017). This study demonstrated that OGP promotes proliferation and exhibits no cytotoxic effects on cPDLSCs. The resazurin assay revealed a significant increase in metabolic activity, indicative of enhanced cell proliferation (Aslantürk 2018), and this finding was corroborated by L/D staining, which showed a greater number of viable, green-stained cells in the OGP-treated group. These results suggest that OGP possesses mitogenic activity toward cPDLSCs. Similar proliferative effects of OGP have been reported in various cell types, including human periodontal ligament stem cells (hPDLSCs), bone marrow-derived mesenchymal stem cells (BM-MSCs) of murine, rabbit, and human origin, osteoblastic MC3T3-E1 cells, osteogenic ROS 17/2.8 cells, and fibroblastic NIH 3T3 cells (Bab et al. 1992; Greenberg et al. 1993; Robinson et al. 1995; Fei et al. 2010; Purbantoro et al. 2022). Mechanistically, OGP is known to activate mitogen-activated protein kinase (MAPK) pathways via Gi protein-coupled receptors (GPCRs), thereby regulating cell proliferation (Gabarin et al. 2001). The CDK2/cyclin A axis has also been implicated in OGP-mediated cell cycle progression and proliferation enhancement (Fei et al. 2010). This study demonstrated that MHAp exhibits the proliferation of cPDLSCs without inducing cytotoxic effects in vitro. Consistent with our findings, previous studies reported no significant cytotoxic differences between MHAp-treated and control groups on day 1 (Wu et al. 2007). Although a transient decline in proliferation was observed on day 5, this may reflect a lag phase in cellular growth rather than a toxic effect. By day 7, MHAp treatment led to a notable increase in cell proliferation, consistent with prior evidence showing that MHAp enhances the proliferation of MC3T3-E1 osteoblastic cells (He et al. 2017). The intrinsic magnetic properties of MHAp-containing scaffolds are known to influence cellular behavior by modulating ion channels and intracellular signaling, particularly after cellular internalization (Singh et al. 2014; Hu et al. 2018). The MHAp has also been known to activate the MAPK signaling pathway, a key regulator of cell proliferation (Zhang and Liu 2002; Wang et al. 2016). These findings suggested that MAPK activation may play a central role in the proliferative response of cPDLSCs to MHAp and possibly act synergistically with OGP to enhance cellular expansion. The brownish appearance observed in HG/MHAp and HG/OGP/MHAp hydrogels was anticipated, as it reflects the intrinsic color of the synthesized MHAp. All hydrogels exhibited interconnected porous structures, consistent with previous reports on SF, sodium alginate (SA), and CaCl2 composite hydrogels (Chuysinuan et al. 2021). The pore size observed in this study falls within the microporous range from 1 to 100 µm (Mays 2007), which is considered favorable for facilitating oxygen and nutrient delivery, vascularization, and bone ingrowth (Kattimani et al. 2016; Mukasheva et al. 2024). Notably, incorporation of OGP and/or MHAp led to a reduction in pore size, which may be attributed to increased cross-linking density and spatial occupation within the hydrogel matrix (Jing et al. 2019; Chuysinuan et al. 2021). FTIR spectroscopy further confirmed the chemical composition of the hydrogels. Characteristic peaks corresponding to amide I (1600–1700 cm⁻¹), amide II (1510–1530 cm⁻¹), and amide III (~1230 cm⁻¹) were detected, indicating the presence of silk fibroin (Jones et al. 2009; Yang et al. 2009; Aliramaji et al. 2017). Additionally, the phosphate (PO43-) peak at 1028 cm−1 confirmed the successful incorporation of MHAp, while also suggesting effective crosslinking with SA (Koutsopoulos 2002; Varma and Babu 2005), implying the successful crosslinking with SA and MHAp. The degradation profile revealed that the unmodified HG was almost completely degraded by day 14, whereas hydrogels containing MHAp retained approximately 60% of their structure. This finding suggested that the degradation of the hydrogels occurs through both chemical hydrolysis and enzymatic digestion, as previously reported (Chuysinuan et al. 2021). The presence of MHAp is likely to contribute to structural stabilization by enhancing resistance to degradation. Although MHAp is also biodegradable, it undergoes degradation through liquid-phase dissolution and cell-mediated resorption (Lu et al. 2002). In the present study, only liquid dissolution may have occurred in the experimental system. Hydrolysis of the hydrogel matrix is primarily attributed to the water-soluble nature of SA, which is susceptible to disruption by negatively charged repulsion within the swollen polymer network. Enzymatic degradation of SF is facilitated by protease XIV, which cleaves the protein at specific amino acid residues, including tyrosine (Tyr), phenylalanine (Phe), tryptophan (Trp), histidine (His), lysine (Lys), and arginine (Brown et al. 2015; Guo et al. 2020). As expected, the swelling profile exhibited an inverse trend to degradation: hydrogels with MHAp showed reduced swelling capacity. This reduction is likely due to MHAp altering the hydrogel architecture by forming additional hydrogel bonds within the polymer network, thus decreasing water absorption. Additionally, the observed smaller pore size in MHAp-containing hydrogels may contribute to the reduced swelling capacity (Di Stefano et al. 2025). These trends are consistent with previous findings (Wu et al. 2020; Chuysinuan et al. 2021; Di Stefano et al. 2025). Mechanical testing revealed that the incorporation of OGP and/or MHAp decreased both compressive strength and stiffness. This reduction in mechanical performance is likely due to the disruption of the polymer network and limited interactions between organic and inorganic components, as similarly observed in previous work (Kim et al. 2017; Chuysinuan et al. 2021). Despite this, proliferation assays and L/D staining confirmed the cytocompatibility of all hydrogels with cPDLSCs in agreement with prior reports (Chuysinuan et al. 2021). The observed enhancement of osteogenic differentiation in cPDLSCs following treatment with OGP- and/or MHAp-incorporated hydrogels highlights the therapeutic potential of this system for clinical bone regeneration applications. The OGP has been shown to stimulate osteogenic differentiation through multiple molecular mechanisms and signaling pathways, including RhoA/Rho-associated protein kinase, heme oxygenase-1 (HO-1), long non-coding RNA (lncRNA) AK141205, CXCL13, as well as canonical pathways, such as TGF-β, BMP, Wnt, Hedgehog, and Notch (Vanella et al. 2010; Chen et al. 2011; Li et al. 2015; Purbantoro et al. 2022). Similarly, MHAp has been reported to activate osteoinductive signaling cascades–including TGF-β, BMP, Wnt, Hedgehog, and Notch pathways–often following MAPK pathway stimulation (Brown et al. 1999; Riobo et al. 2006; Sapkota et al. 2007; Bikkavilli et al. 2008; Yamashita et al. 2013). In addition, MHAp has superior bone regenerative properties compared to the pristine nanohydroxyapatite (Hu et al. 2018; Russo et al. 2018). Interestingly, SF itself has been implicated in promoting osteogenesis through modulating Notch, Wnt, BMP, TGF-β, insulin-like growth factor (IGF), and platelet-derived growth factor (PDGF) pathways, further contributing to the differentiation process (Farokhi et al. 2018). Based on this collective evidence, it is reasonable to conclude that the enhanced osteogenic differentiation observed in this study results from a synergistic interaction among SF, OGP, and MHAp, rather than from any single component alone. Given the demonstrated potential of the hydrogels for bone regeneration, a quantitative proteomics approach was performed to further investigate the phenomenon underlying the enhanced osteogenic differentiation of cPDLSCs in vitro. Comparative study with the control HG group revealed that incorporation of OGP and/or MHAp led to the regulation of unique proteome patterns, as illustrated by Venn diagrams and hierarchical cluster heat maps. Notably, a greater number of differentially expressed proteins were detected on day 7 compared to day 14. This decline in protein count over time may be attributed to the progression of cPDLSCs into the late stages of osteogenic differentiation, during which some cells underwent apoptosis, thereby reducing the viable cell population and detectable proteome complexity (Infante and Rodríguez 2018). These protein expression patterns were consistent with volcano plot analysis, which showed that HG/OGP-treated cells expressed fewer significantly regulated proteins compared to the HG/MHAp and HG/OGP/MHAp groups at both time points. Despite differences in the number and identity of proteins, GO analysis of BP, MF, and CC indicated similar trends across all groups. This suggests that while the treatments induced distinct proteomic profiles, the underlying biological dynamics governing osteogenic differentiation were largely conserved. These findings emphasize that each hydrogel composition modulates a unique proteomic landscape while contributing to a shared osteogenic trajectory. To further elucidate the molecular mechanisms driving the osteogenic differentiation of cPDLSCs under hydrogel treatment, Reactome pathway enrichment analysis was conducted. This analysis revealed activation of key osteogenic-related signaling pathways, including TGF-β superfamily, Wnt, and Notch pathways, which are known to play main roles in MSC differentiation toward the osteogenic lineage (Deng et al. 2008; Chen et al. 2016). To validate the functional relevance of these pathways, selective inhibitors were employed: SB-431542 for TGF-β, Dorsomorphin for BMP, DAPT for Notch, and Dkk-1 for canonical Wnt signaling. Significant reductions in biomineralization following treatment with SB-431542, Dorsomorphin, and DAPT confirm that TGF-β, BMP, and Notch signaling pathways are critical mediators of osteogenesis induced by HG/OGP/MHAp. The TGF-β and BMP belong to the same signaling family and are well-established regulators of bone formation (Wang et al. 2025). This study also observed dynamic regulation of TGFB1, which was upregulated on day 7 and downregulated on day 14, suggesting a time-dependent activation of TGF-β signaling that could be effectively attenuated through pathway inhibition. Notably, DAPT significantly suppressed biomineralization, supporting the role of Notch signaling in early osteogenic commitment, as previously reported (Purbantoro et al. 2022). Additionally, BMP signaling has been shown to interact with and influence Notch activation during osteogenesis (Manokawinchoke et al. 2021), further supporting their independent regulatory roles. There was no significant difference in biomineralization between cPDLSCs treated with or without Dkk-1, suggesting that canonical Wnt signaling may not play a dominant role in osteogenic differentiation under HG/OGP/MHAp treatment. This contrasts with previous findings where Dkk-1 inhibited biomineralization in human PDLSCs under interleukin-6 (IL-6) stimulation (Purwaningrum et al. 2023). The Dkk-1 is a well-established inhibitor of the canonical Wnt pathway and functions by binding to the LRP5/6 co-receptors, thereby blocking Wnt ligand signaling (Liu et al. 2022). This pro-osteogenic effect of Dkk-1 found in this study is assumed to be caused by the osteogenic differentiation of cPDLSCs is either Wnt-independent or Wnt-non-canonical-dependent. Similar findings have been reported in canine dental pulp stem cells (cDPSCs), where Dkk-1 promoted rather than suppressed osteogenic differentiation (Nantavisai et al. 2020). Mechanistically, Dkk-1 has been shown to upregulate Runx2 expression under specific conditions, which can lead to enhanced osteogenesis (Liu et al. 2022). These context-dependent effects highlight the complexity of Wnt signaling, which can vary across cell types and experimental conditions (Grotheer et al. 2021). Therefore, the influence of Dkk-1 may be modulated by cell-intrinsic factors or by crosstalk with other signaling pathways in the differentiation microenvironment. In conclusion, the injectable SF hydrogel incorporating OGP and MHAp exhibited non-cytotoxic, demonstrated excellent biocompatibility, promoted cPDLSCs proliferation, and significantly enhanced osteogenic differentiation in vitro. These effects were predominantly mediated through the activation of TGF-β, BMP, and Notch signaling pathways (Figure 8). Given its injectability, bioactivity, and safety profile, this hydrogel system holds strong potential for clinical translation, particularly for the treatment of alveolar bone defects in veterinary medicine. Summary of signaling pathways involved in osteogenic differentiation of cPDLSCs under hydrogel treatment. (1) HG/OGP/MHAp activates TGF-β, BMP, and Notch signaling pathways. (2) The activation leads to the expression of osteogenic markers that result in increased osteogenic differentiation of cPDLSCs. Note: HG = hydrogel, MHAp = magnetic nanohydroxyapatite, OGP = osteogenic growth peptide, TGF-β = transforming growth factor β, BMP = bone morphogenic protein, OSX = osterix, ALP = alkaline phosphatase, COL1A1 = collagen type I alpha 1 chain, OPN = osteopontin. Supplementary Material Table S1 Primer Sequence.docx Table S1 Primer Sequence.docx